Coaptite 8005M0
Coaptite 8005M0 is a dermal tissue reconstructive material (FDA Class III; FDA product code LNM, Agent, Bulking, Injectable For Gastro-Urology Use) made by Merz North America, Inc., listed in FDA GUDID since 15 Oct 2024 (UDI-DI 10810235030645), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10810235030645 | Date15 Oct 2024 | StatusListed |
Official records
- AccessGUDID record 10810235030645
From the FDA record
- Device description
- The Coaptite Injectable implant is a permanently implanted device to treat women who have severe stress urinary incontinence due to poorly functioning urethral sphincter muscles
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Coaptite
- Generic name
- Dermal tissue reconstructive material, synthetic mineral
- Model / reference
- 8005M0
- Primary DI / UDI-DI
- 10810235030645
- FDA product code
- LNM
- GMDN term
- Dermal tissue reconstructive material, synthetic mineral
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code LNM (Agent, Bulking, Injectable For Gastro-Urology Use).
- Macroplastique Implants MPQ-2.5 by Uroplasty, LLC
- Bard URYX Urethral Bulking Agent by C. R. Bard, Inc.
- Macroplastique Implants by Uroplasty, LLC
- Solesta Injectable Gel by Palette Life Sciences Inc.
- Contigen Bard Collagen Implant by Allergan
- Deflux Injectable Gel by Palette Life Sciences Inc.
- Bulkamid Urethral Bulking System by Boston Scientific
- Durasphere Injectable Bulking Agent by Carbon Medical Technologies, Inc.
- Enteryx Procedure Kit by Boston Scientific